Regenerative medicine
Regenerative medicine uses cells and similar materials, and in Japan it is governed by the Act on the Safety of Regenerative Medicine. Our part is to help you find an institution that has completed the required procedures, and to make the rules and risks clear.
How Japan regulates it
- Before offering regenerative medicine, an institution must have its provision plan reviewed by a certified committee and file it with the Ministry of Health, Labour and Welfare. Plans are grouped into Class I, II and III by risk.
- Cells must be cultured and processed in a facility that holds a licence or has filed a notification.
- The ministry publishes the list of institutions that have filed plans. Anyone can look it up.
- Filing a plan is a procedural requirement. It does not mean the state has endorsed the treatment's effectiveness. Most treatments are paid for out of pocket, and the strength of the scientific evidence varies.
What we do
- Verify
- We check the institution's plan number, class and scope, and show you how to look it up yourself.
- Translate
- We translate the key points of the explanation and consent documents, and a medical interpreter joins your consultation.
- Arrange
- We book the consultation, tests and treatment dates and coordinate your stay in Japan.
- Keep records
- We keep the documents so you can explain the treatment to other physicians later.
What we do not do
- We do not judge whether a therapy works, and we do not promise improvement or anti-ageing effects.
- We do not introduce treatments for which no provision plan has been filed.
- We do not introduce institutions currently under a suspension or improvement order from the ministry.
Risks and limits
- Regenerative medicine carries risk, including infection, allergic reaction and blood clots. In recent years patients have died after cell therapy in Japan, and the ministry has issued emergency orders to the institutions involved.
- Treatments using exosomes or stem cell culture supernatant are currently outside the provision plan system, and no such product is approved as a medicine in Japan. The ministry is discussing whether to regulate them.
- Costs are high and entirely out of pocket. Disputes over care received in Japan generally have to be handled in Japan.
- Decide only after hearing the physician's explanation and talking with your family and your own doctor.
This page reflects public information as of November 2026. If the rules change, the ministry's announcements take precedence.